Terry Kelly
Corporate Officer/Principal bei VOLITIONRX LIMITED
Profil
Terry Kelly is currently the Chief Innovation Officer at VolitionRX Ltd.
Prior to this, she worked as the Director of Research and Development at Active Motif, Inc. Ms. Kelly holds a doctorate degree from the University of California, Los Angeles.
Aktive Positionen von Terry Kelly
| Unternehmen | Position | Beginn |
|---|---|---|
| VOLITIONRX LIMITED | Corporate Officer/Principal | 01.03.2020 |
Ehemalige bekannte Positionen von Terry Kelly
| Unternehmen | Position | Ende |
|---|---|---|
Active Motif, Inc.
 Active Motif, Inc. BiotechnologyHealth Technology Active Motif, Inc. develops and distributes molecular biology-based research tools and kits that help researchers elucidate the function, regulation and interactions of the genes and their encoded proteins. Its products include New TransAM, Methylated Histones, and Histone Purification Mini Kit. The company was founded in 1999 and is located in Carlsbad, CA. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Terry Kelly
| University of California, Los Angeles | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| VOLITIONRX LIMITED | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Active Motif, Inc.
Active Motif, Inc. BiotechnologyHealth Technology Active Motif, Inc. develops and distributes molecular biology-based research tools and kits that help researchers elucidate the function, regulation and interactions of the genes and their encoded proteins. Its products include New TransAM, Methylated Histones, and Histone Purification Mini Kit. The company was founded in 1999 and is located in Carlsbad, CA. | Health Technology |
